期刊文献+

奥曲肽对食管癌细胞株Eca9706增殖的影响 被引量:1

Effect of octreotide on the proliferation of esophageal carcinona cells Eca9706
下载PDF
导出
摘要 目的 研究奥曲肽对食管癌细胞株Eca970 6增殖的影响。方法 将不同浓度的奥曲肽加入食管癌细胞 ,用四甲基偶氮唑蓝 (MTT)法测定细胞生长抑制效应 ,3 H -胸腺嘧啶核苷 (3 H -TdR)掺入实验测定对DNA合成的影响 ,显微镜下观察细胞形态变化 ,流式细胞仪 (FCM )检测细胞周期。结果 奥曲肽对Eca970 6细胞的生长及DNA合成均有抑制作用 ,显微镜下可见明显的细胞病变 ,细胞变圆、变小、脱落 ,FCM显示奥曲肽作用后 ,G0 /G1期细胞增多 ,S期、G2 /M期细胞减少。结论 奥曲肽能明显抑制食管癌细胞株Eca970 6的DNA合成 ,并能形成G0 /G1期阻滞 ,使细胞存活率下降 ,表明奥曲肽显著抑制Eca970 6的增殖。 Objective To investigate the effect of octreotide on the proliferation of esophageal carcinoma cells Eca9706. Methods Esophageal carcinoma cells were treated with octreotide.The growth suppression effect on the cells was evaluated by MTT assay. The effect of octreotide on DNA synthesis was evaluated by 3 H-thymidine( 3H-TdR) incorporation. Morphologic changes of cells were observed under microscope. Cell cycle was detected by flow cytometry(FCM). Results Octreotide obviously inhibited the growth and DNA synthesis of Eca9706 cells. Obvious pathologic change of cells were observed under microscope, cells became round , small and exfoliating. The FCM analysis showed that the ratio of esophageal carcinoma cells of G 0/G 1 phase increased and cells of S phase and G 2/M phase decreased .Conclusion Octreotide can obviously inhibit the DNA synthesis of Eca9706 cells and cause G 0/G 1 blocking and cell survival rate decreased, indicating that octreotide can significantly inhibit the proliferation of esophageal carcinoma cells Eca9706.
出处 《山西医科大学学报》 CAS 2003年第5期409-411,共3页 Journal of Shanxi Medical University
基金 郧阳医学院重点科研课题资助项目
关键词 奥曲肽 食管癌 Eca9706增殖 影响 癌细胞株 octreotide esophageal neoplasms cells,cultured
  • 相关文献

参考文献9

二级参考文献15

  • 1张达荣,萧树东,李继强,袁济民,李文美,张丽冬,巨卫平,王少先,王瑞明,朱志仁,江绍基.奥曲肽和垂体后叶素对门脉高压血流动力学的影响[J].中华消化杂志,1995,15(2):85-88. 被引量:125
  • 2叶维法 钟振义.当代肝胆疾病治疗学[M].四川科学技术出版社,辽宁科学技术出版社,江苏科学技术出版社,1998.347~352.
  • 3Thangaraju M,Cancer Res,1999年,59卷,1649页
  • 4Samuels BL.Management of recurrent dosmoid tumor after surgery and radiation:role of cytotoxic and non-cytotoxic therapies.Surg Oncol,1999,8:191-196.
  • 5Kaye SB,Eisenhauer EA,Hamilton TC.New non-cytotoxic approaches to ovarian cancer.Ann Oncol,1999,10(suppl):165-168.
  • 6Pedersen-Bjergaard U,Andersen M,Hansen PB.Drug-specific characteristics of thrombocytopenia caused by non-cytotoxic drugs.Eur J Clin Pharmacol,1998,54:701-706.
  • 7Sadji Z,Le Romancer M,Hervatin F,et al.Somatostatin analogs stimulate DNA-dependent protein kinase activity in human gastric tumoral cell-line HGT1.Life Sci,1999,65:2829-2835.
  • 8Reubi JC.A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth.Acta Endocrinol(copenh),1985,109:108-114.
  • 9Pollak MN,Schally AV.Mechanisms of antineoplastic action of somatostatin analogs.Proc Soc Exp Biol Med,1998,217:143-152.
  • 10Uefuji K,Ichikura T,Mochizuki H.Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer.Clin Cancer Res,2000,6:135-138.

共引文献51

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部